Literature DB >> 12824021

Heterocyclic thrombin inhibitors. Part 2: quinoxalinone derivatives as novel, potent antithrombotic agents.

Uwe J Ries1, Henning W M Priepke, Norbert H Hauel, Sandra Handschuh, Gerhard Mihm, Jean M Stassen, Wolfgang Wienen, Herbert Nar.   

Abstract

Quinoxalinone derivatives as prototypes of dual thrombin and factor Xa inhibitors have been discovered. Nanomolar inhibition of both coagulation enzymes resulted in very potent antithrombotic activity in vitro.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12824021     DOI: 10.1016/s0960-894x(03)00443-8

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  6 in total

1.  A novel route to synthesize libraries of quinoxalines via Petasis methodology in two synthetic operations.

Authors:  Muhammad Ayaz; Justin Dietrich; Christopher Hulme
Journal:  Tetrahedron Lett       Date:  2011-09-21       Impact factor: 2.415

2.  Concise route to a series of novel 3-(tetrazol-5-yl)quinoxalin-2(1H)-ones.

Authors:  Steven Gunawan; Gary Nichol; Christopher Hulme
Journal:  Tetrahedron Lett       Date:  2012-01-28       Impact factor: 2.415

3.  Methyl 4-(1H-benzimidazol-2-yl)benzoate trihydrate.

Authors:  Parna Gupta; Soumik Mandal
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-10-09

4.  2-Chloro-methyl-1-methyl-1,3-benzimidazole.

Authors:  Jie Han; Jun Zhang; Qi Yang; Ming-Gao Zhao; Guang Fan
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-07-23

5.  Photoinitiated decarboxylative C3-difluoroarylmethylation of quinoxalin-2(1H)-ones with potassium 2,2-difluoro-2-arylacetates in water.

Authors:  Yanhui Gao; Lulu Zhao; Tianyi Xiang; Pinhua Li; Lei Wang
Journal:  RSC Adv       Date:  2020-03-12       Impact factor: 4.036

6.  Design, synthesis, and molecular docking studies of diphenylquinoxaline-6-carbohydrazide hybrids as potent α-glucosidase inhibitors.

Authors:  Keyvan Pedrood; Zahra Rezaei; Kimia Khavaninzadeh; Bagher Larijani; Aida Iraji; Samanesadat Hosseini; Somayeh Mojtabavi; Mehdi Dianatpour; Hossein Rastegar; Mohammad Ali Faramarzi; Haleh Hamedifar; Mir Hamed Hajimiri; Mohammad Mahdavi
Journal:  BMC Chem       Date:  2022-07-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.